Stock Events

Stock Events

Arovella Therapeutics (ARVEF) Q1 2026 Earnings

19FebConfirmed

Q3 2024

Q1 2025

Q3 2025

Q1 2026

-0

-0

-0

-0

Details

Expected EPS

-0.002669

Actual EPS

-0.0010676

Surprise EPS

0

Surprise Percent

+60%

Description

Arovella Therapeutics (ARVEF) has reported earnings of -0.0010676 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.